Banking on robust above-market growth across all business units, BSX is expected to have witnessed strong international momentum in the first quarter.

Boston Scientific will face more benign competition than previously feared when it comes to pulsed field ablation, according ...

Holston Valley Medical Center is the first hospital in East Tennessee, Southwest Virginia and Southeast Kentucky to offer ...

Needham upgraded Boston Scientific Corp (NYSE:BSX) to “Buy”, saying competition from pulsed field ablation (PFA) rivals looks less intense for its key product than it was earlier feared, and citing ...

RBC Capital is still sweet on Boston Scientific, holding firm on its $116 price target and an Outperform rating. The analyst ...

We came across a bullish thesis on Boston Scientific Corporation (BSX) on Substack by Magnus Ofstad. In this article, we will ...

Despite a shaky quarter due to U.S.-China trade tensions and a 6% dip in stock price, Boston Scientific still flexed its ...

Cartesian Therapeutics Inc. followed up December’s phase IIb data with more good news regarding Descartes-08, offering 12-month efficacy and safety results that whetted Wall Street’s appetite for the ...

Pulsed field ablation using Boston Scientific Corp.’s Farapulse system was non-inferior and even superior, slightly, to Medtronic plc’s Artic Front Advance cardiac cryoablation system in treating ...

The Farapulse system in full with the Farawave ablation catheter, Farastar ablation generator and Faradrive steerable sheath. [Image courtesy of Boston Scientific] Boston Scientific (NYSE ...

Abbott has trailed medtech competitors in bringing a PFA device to market, but now plans to accelerate its European rollout in the second half of this year, after beginning with EU physicians familiar ...

J&J pauses Varipulse pulsed field ablation system's US debut following 4 reports of strokes The Farapulse pulsed field ablation system received its first CE mark in early 2021, shortly before it ...